Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10012268 | 0.89 | TDP1 (0.42) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL10011389 | 0.84 | TDP1 (0.39) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL10687652 | 0.83 | TDP1 (0.43) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL22566348 | 0.82 | TDP1 (0.40) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL10011778 | 0.82 | TDP1 (0.40) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL10011785 | 0.81 | TDP1 (0.39) | TDP1TSHRCYP3A4MAPTCACNA1B | |
| SCHEMBL22556024 | 0.80 | TDP1 (0.41) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL10012856 | 0.80 | TDP1 (0.41) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL22556022 | 0.80 | TDP1 (0.41) | TDP1TSHRCYP3A4ALDH1A1MAPT | |
| SCHEMBL2639414 | 0.79 | TDP1 (0.46) | TDP1TSHRCYP3A4ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114025759-A | Compounds and methods for treating ocular diseases | 阿祖拉眼科有限公司 | 2022-02-08 | — | — | CN | disclosed |